mediTective
Software Engine for Polyp Detection in the Gastrointestinal Tract
Health Tech & Life Sciences
Non Active, Apr 2024 ceased to operate
Company Overview
Snapshot
Founded in March 2019 by David Rainis and Ethan Kushner, mediTective operates with 1–10 employees. The company ceased operations in April 2024.
Business overview
mediTective specializes in AI-driven medical imaging, developing Sherlock, a software engine designed to detect polyps in the gastrointestinal tract. This technology leverages image analysis and deep-learning algorithms to serve the healthcare industry, particularly clinics, hospitals, and doctors, by enhancing diagnostic capabilities in gastroenterology and cancer detection. The company operates within the Health Tech & Life Sciences sector, focusing on digital healthcare and medical decision support.
Log in to access full profile ›Company Intelligence Q&A
- What is mediTective's primary focus?
- mediTective specializes in AI-driven medical imaging, specifically developing a software engine for polyp detection in the gastrointestinal tract using image analysis and deep-learning algorithms.
- When was mediTective founded?
- mediTective was founded in March 2019.
- Who are the founders of mediTective?
- mediTective was founded by David Rainis, who serves as CEO, and Ethan Kushner, who is the Co-founder and Chief Marketing Officer.
- What is the status of mediTective?
- mediTective ceased to operate in April 2024.
- Which markets does mediTective target?
- mediTective targets the healthcare market, specifically clinics, hospitals, and doctors, with a focus on gastroenterology and cancer diagnostics in Israel and Germany.